Search – Page 64 – Indianapolis Business Journal

Home » Search

Articles

U.S. to set up plan allowing prescription meds from Canada

July 31, 2019 | Associated Press

The Trump administration said Wednesday it will create a pathway allowing Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of opposition from federal health authorities.

Eli Lilly tops quarterly expectations, raises forecast

July 30, 2019 | Associated Press

A jump in sales from the diabetes treatment Trulicity helped push the Indianapolis-based drugmaker to a better-than-expected second quarter.

Drugmaker group boosts lobbying as Trump’s push to lower prices stalls

July 22, 2019 | Bloomberg News

The Pharmaceutical Research and Manufacturers of America, which represents leading drugmakers including Eli Lilly and Co., reported spending $6.2 million in the quarter. Meanwhile, Lilly boosted its own spending on lobbying.

EDITORIAL: National Urban League event tees up important conversations

July 19, 2019 | IBJ Staff

In a few days, some of the nation’s most important African American leaders—in business, politics, entertainment and philanthropy—will descend on Indianapolis for the National Urban League Conference.

Trump kills key drug price proposal he once embraced

July 12, 2019

The drug rebate rule would have ended a widespread practice in which drugmakers give rebates to insurance middlemen in government programs such as Medicare. The idea was to channel that money to consumers instead.

Lilly losing two senior executives, including Bio-Medicines chief

July 11, 2019

Lilly shares dropped 4.6 percent in early trading after the company said Christi Shaw was leaving and Mike Harrington planned to retire.

Elanco in merger talks with pharmaceutical giant Bayer, sources say

July 9, 2019

The multibillion-dollar merger would combine Elanco, the fourth-largest global player in animal health, with Bayer’s pet-health division, which ranks fifth in veterinary medicine, Reuters reported. The combination would create a dominant force in the industry.

Judge strikes down rule requiring drug ads to reveal prices

July 9, 2019

Responding to a lawsuit by Eli Lilly and two other companies, a federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.

IBE business conference event schedule

July 2, 2019

All business conference events are free; however, seating is limited, so online registration is recommended.

IU Health executive Kitchell leaving ‘for other opportunities’

June 28, 2019

Ryan Kitchell oversees a wide variety of business operations at the state’s largest health system. His departure comes as IU Health is in the midst of numerous capital projects.

Debunking medical myths all in a day’s work for IU’s Dr. Aaron Carroll

June 27, 2019 | John Russell

Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.

BioCrossroads chooses retired Lilly exec as new CEO

June 25, 2019

Patricia Martin, 58, former chief operating officer of Lilly’s diabetes division, will start her new job July 1, leading an organization that promotes and invests in the state’s life sciences sector.

Groups protest insulin prices outside Lilly headquarters

June 20, 2019

Several diabetes and health care advocacy groups on Thursday announced a seven-figure fundraising campaign to help fund their fight against what they consider “skyrocketing” insulin prices.

TechPoint, TMap get aggressive to lure ex-pat techies to Indiana

June 20, 2019

Local tech advocacy group TechPoint is partnering with TMap, an Indianapolis startup headed by former Angie’s List CEO Bill Oesterle, and five blue-chip companies to bring far flung native Hoosiers back to the state to work.

Lilly’s push into pain research starting to pay off

June 19, 2019

In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.

Pfizer expanding in cancer with $10.6B deal for Array BioPharma

June 17, 2019

Array’s stock was already at a record before the deal announcement, following the company’s news last month of positive clinical trial results using Braftovi and Mektovi with Indianapolis-based Eli Lilly and Co.’s Erbitux.

Drugmakers sue Trump administration to halt advertising rule

June 17, 2019

Some of the biggest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., sued the Trump administration to try and block a rule that would force them to put the price of their drugs in television advertisements.

Lilly Endowment saw huge jump in assets in 2018

June 14, 2019

The Indianapolis-based foundation’s run-up solidified its position as one of the largest private charitable foundations in the country.

Owners of Union 525 incubator plan $10M building on South Meridian

June 13, 2019

The tech incubator owners plan to construct a six-story building directly south of the existing Union 525 building.

DePauw grants $1M from endowment to student investment group